Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Crossref DOI link: https://doi.org/10.1007/s00262-017-1967-1
Published Online: 2017-02-25
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dummer, Reinhard
Hoeller, Christoph
Gruter, Isabella Pezzani
Michielin, Olivier
Funding for this research was provided by:
Amgen (Medical writing support was funded by Amgen)
License valid from 2017-02-25